Demographic characteristics of Round 1 and 2 respondents
| Variable | Round 1 | Round 2 |
| N=64 | N=64 | |
| Gender, n (%) | ||
| Male | 27 (42) | 25 (39) |
| Female | 37 (58) | 39 (61) |
| Age, n (%) | ||
| 20–29 years | 1 (2) | 1 (1) |
| 30–39 years | 14 (22) | 11 (17) |
| 40–49 years | 21 (33) | 21 (33) |
| 50–59 years | 17 (27) | 18 (28) |
| ≥60 years | 11 (17) | 13 (20) |
| Country of practice, n (%) | ||
| Africa | 1 (2) | 1 (2) |
| Asia | 6 (9) | 6 (9) |
| Europe | 13 (20) | 13 (20) |
| Middle East | 3 (5) | 3 (5) |
| North America | 12 (19) | 15 (24) |
| Oceania | 22 (34) | 20 (31) |
| South America | 6 (9) | 6 (9) |
| Discipline and specialty, n (%) | ||
| Doctor | 22 (34) | 22 (34) |
| Anaesthesia/ICU | 9 (41) | 7 (32) |
| Surgery | 4 (18) | 5 (23) |
| Paediatrics | 3 (14) | 5 (23) |
| Interventional radiology | 2 (9) | 2 (9) |
| Other | 4 (20) | 3 (15) |
| Nurse | 39 (61) | 38 (60) |
| Vascular access | 8 (21) | 9 (24) |
| Intensive care | 7 (18) | 7 (18) |
| Academia/research | 5 (13) | 5 (13) |
| Oncology/haematology | 5 (13) | 5 (13) |
| Infection prevention and control | 4 (10) | 3 (8) |
| Paediatrics | 3 (8) | 3 (8) |
| Infusion therapy* | 7 (18) | 6 (16) |
| Other | 3 (5) | 4 (6) |
| Formal vascular access qualification, n (%)† | ||
| No | 28 (43) | 25 (38) |
| Yes | 11 (17) | 13 (21) |
| Not applicable | 25 (39) | 26 (41) |
| Patient population | ||
| Adult | 30 (47) | 25 (39) |
| Mixed | 24 (38) | 26 (41) |
| Paediatric/neonate | 10 (16) | 13 (20) |
*Includes home infusion.
†Nurse only, n=39.
ICU, intensive care unit.